NRC Health

Name: NRC Health standardized financial statements, quarterly
Creator: Listed

NRCNasdaqCIK 70487IndustrialsFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$35.4m, Q2 FY2026

Operating income−$3.2m, Q2 FY2026

Net income−$3.3m, Q2 FY2026

NRC Health, income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	37.9	38.0	35.3	35.0	35.8	36.9	33.6	34.0	34.6	35.2	34.8	35.4
Selling, general and administrative	$m	11.8	11.1	11.3	11.2	11.0	11.5	10.4	17.7	12.3	14.4	13.4	22.9
Operating income	$m	10.0	11.7	8.8	8.9	8.0	9.6	8.6	1.6	7.7	4.7	5.6	(3.2)
Interest expense	$m	0.2	0.3	0.6	0.6	0.7	0.7	0.9	1.0	1.5	1.4	1.3	1.3
Income tax	$m	2.2	2.6	1.8	2.1	1.6	2.3	1.9	0.7	2.2	1.5	1.2	(1.3)
Net income	$m	7.9	8.9	6.4	6.2	5.7	6.6	5.8	(0.1)	4.1	1.8	3.2	(3.3)
Diluted EPS	$ per share	0.32	not reported	0.27	0.26	0.24	not reported	0.25	(0.01)	0.18	not reported	0.14	(0.15)
Basic EPS	$ per share	0.32	not reported	0.27	0.26	0.24	not reported	0.25	(0.01)	0.18	not reported	0.14	(0.15)

Balance sheet

Cash and equivalents$3.3m, Q2 FY2026

Long-term debt$86.0m, Q2 FY2026

Shareholders' equity$6.5m, Q2 FY2026

NRC Health, balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	3.8	6.7	1.7	0.5	3.5	4.2	2.5	5.3	2.2	4.1	2.5	3.3
Current assets	$m	24.7	24.4	20.0	17.0	20.7	19.6	20.4	25.3	20.4	20.2	20.0	22.8
Total assets	$m	120	122	121	119	132	133	135	141	136	135	135	136
Current liabilities	$m	40.8	36.2	48.9	45.7	44.3	35.9	37.8	35.9	38.6	36.6	38.5	35.0
Total liabilities	$m	62.3	73.5	84.0	78.9	97.2	101	106	120	121	121	121	130
Long-term debt	$m	18.9	29.5	27.6	25.7	44.9	57.9	58.7	77.0	76.0	75.0	74.0	86.0
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	4.0	not reported	4.0
Shareholders' equity	$m	57.9	49.0	36.9	40.2	34.6	31.3	29.7	21.3	14.3	14.0	13.5	6.5

Cash flow

Operating cash flow$1.4m, Q2 FY2026

Capital expenditure$1.3m, Q2 FY2026

Share repurchases$7.6m, Q2 FY2026

NRC Health, cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$m	9.8	11.7	12.0	6.8	9.4	6.4	6.6	(1.1)	13.8	7.2	7.2	1.4
Capital expenditure	$m	4.5	3.8	4.1	5.3	1.6	4.4	3.0	3.0	3.6	1.1	1.8	1.3
Dividends paid	$m	27.5	2.9	2.9	2.9	2.9	2.8	2.8	2.7	2.8	2.7	3.6	3.6
Share repurchases	$m	0.3	15.0	15.0	0.0	8.5	7.4	4.9	6.0	9.3	0.0	1.9	7.6

Diluted shares (weighted)22.01m, Q2 FY2026

NRC Health, shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	24.8	24.7	24.7	24.7	24.0	23.9	23.7	23.0	22.7	22.1	21.9	22.0

Shares outstanding: 22.12m at Jul 31, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. Listed shows no prices and gives no investment advice.